NR1H4 and breast carcinoma: Also consistent with enhanced proliferation, downregulated pathways associated with suppressing proliferation and/or increasing apoptosis of breast cancer cells (i.e., FXR/RXR activation and LXR/RXR activation) [20–22] were also identified.